Crossref
BOS172738: a next-generation rearranged during transfection inhibitor enters the evolving landscape of rearranged during transfection-targeted therapy
Annals of Thyroid · 2026-07 · 11 · 12-12
DOI: 10.21037/aot-2026-0017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Thyroid, 2026-07. Verfasst von Dipen Patel und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Patel, D., Sukrithan, V., & Konda, B. (2026). BOS172738: a next-generation rearranged during transfection inhibitor enters the evolving landscape of rearranged during transfection-targeted therapy. Annals of Thyroid, 11, 12-12. https://doi.org/10.21037/aot-2026-0017
Vancouver
Patel D, Sukrithan V, Konda B. BOS172738: a next-generation rearranged during transfection inhibitor enters the evolving landscape of rearranged during transfection-targeted therapy. Annals of Thyroid. 2026;11:12-12. doi:10.21037/aot-2026-0017
BibTeX
@article{Patel2026,
author = {Patel, Dipen and Sukrithan, Vineeth and Konda, Bhavana},
title = {BOS172738: a next-generation rearranged during transfection inhibitor enters the evolving landscape of rearranged during transfection-targeted therapy},
journal = {Annals of Thyroid},
year = {2026},
volume = {11},
pages = {12--12},
doi = {10.21037/aot-2026-0017}
}
EUVIMED